Zobrazeno 1 - 10
of 632
pro vyhledávání: '"Immune mediated necrotizing myopathy"'
Publikováno v:
The Egyptian Journal of Neurology, Psychiatry and Neurosurgery, Vol 60, Iss 1, Pp 1-8 (2024)
Abstract Background Idiopathic inflammatory myopathies are a group of autoimmune conditions primarily affecting the proximal muscles and can involve other organs, such as the skin, joints, and lungs. Many diagnostic and classification criteria have b
Externí odkaz:
https://doaj.org/article/405c82d2e6a44426b16e318638534f4f
Autor:
Mariko Ogawa-Momohara, Yoshinao Muro
Publikováno v:
Immunological Medicine, Pp 1-13 (2024)
In recent years, various myositis-specific and myositis-associated autoantibodies have been identified in idiopathic inflammatory myopathies, including dermatomyositis (DM), anti-synthetase syndrome (ASS), immune-mediated necrotizing myopathy (IMNM),
Externí odkaz:
https://doaj.org/article/26650075af5948d2856f9a568dfda342
Publikováno v:
Arthritis Research & Therapy, Vol 26, Iss 1, Pp 1-10 (2024)
Abstract Objective Anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR) autoantibodies are one of the myositis-specific antibodies which is associated with immune-mediated necrotizing myopathy (IMNM). However, the relationship between anti-HM
Externí odkaz:
https://doaj.org/article/4d83fe46a01941be921616a932181b64
Autor:
Braun Andreas Albert, Atiya Monika, Göhner Katja, Hortobagyi Tibor, Burkhardt Tobias, Schreiner Bettina
Publikováno v:
Open Medicine, Vol 19, Iss 1, Pp 1541-7 (2024)
Statin use can lead to various muscle-related issues, including benign creatine kinase (CK) elevations, myalgias, toxic myopathies, rhabdomyolysis, and immune-mediated necrotizing myositis (IMNM), which primarily affects older males. IMNM presents wi
Externí odkaz:
https://doaj.org/article/23b6c2e2b163427788bdc05df33eb614
Autor:
MengTing Yang, JingChu Yuan, YiKang Wang, HongJun Hao, Wei Zhang, ZhaoXia Wang, Yun Yuan, YaWen Zhao
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
ObjectiveWe aimed to explore the efficacy and safety of efgartigimod in patients with refractory immune-mediated necrotizing myopathy (IMNM).MethodsThis open-label pilot observational study included seven patients with refractory IMNM, all of whom re
Externí odkaz:
https://doaj.org/article/b5f83b7bae674e1a88afab3cf8c0bd81
Autor:
LIU Hongjiang, XIE Qibing
Publikováno v:
Zhenduanxue lilun yu shijian, Vol 23, Iss 03, Pp 270-277 (2024)
Immune-mediated necrotizing myopathy (IMNM) is a significant, subtype of idiopathic inflammatory myopathy（IIM）, characterized by symmetrical proximal limb muscle weakness and markedly elevated serum creatine kinase levels. Some patients may also
Externí odkaz:
https://doaj.org/article/123b34a1f73e4779a351ce1dabb810bc
Autor:
Takashi Kurashige, Rie Nakamura, Tomomi Murao, Naoko Mine, Mayu Sato, Riho Katsumata, Yuhei Kanaya, Yoriko Dodo, Tomohito Sugiura, Tomohiko Ohshita
Publikováno v:
BMC Immunology, Vol 25, Iss 1, Pp 1-10 (2024)
Abstract Background Immune-mediated necrotizing myopathy (IMNM) is an idiopathic inflammatory myopathy (IIM). Though patients with IMNM were not considered to show skin rash, several reports have showed atypical skin conditions in patients with anti-
Externí odkaz:
https://doaj.org/article/bd8d7e0e042e4dfb9b8d33be6127bce3
Autor:
A. A. Kolomeychuk
Publikováno v:
Научно-практическая ревматология, Vol 61, Iss 6, Pp 689-699 (2024)
Idiopathic inflammatory myopathies (IIM) are a group of chronic autoimmune conditions characterized by proximal muscle weakness and potentially accompanied by a range of extramuscular clinical manifestations. There are subtypes of IIM including derma
Externí odkaz:
https://doaj.org/article/dd652d21d1fd457087cc685749c05b23
Publikováno v:
Zhenduanxue lilun yu shijian, Vol 22, Iss 03, Pp 247-254 (2023)
Objective: To explore the clinical characteristics of anti-SRP antibody positive immune-mediated necrotizing myopathy (IMNM) with anti-TRIM21/Ro52 antibody positive. Methods: The data of 57 patients with anti-SRP antibody positive (+) IMNM admitted t
Externí odkaz:
https://doaj.org/article/4eef1640400c4ae49ce16edd84c17a76
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
BackgroundImmune-mediated necrotizing myopathies (IMNM) is a rare disease that was first described in 2004. Due to the lack of large case series, there are no formal treatment recommendations for IMNM.MethodsWe presented a case of a 47-year-old woman
Externí odkaz:
https://doaj.org/article/44ad5224ea8042d4be5f9c2b8479cffd